Preventing Cushing: Iatrogenic Cushing Syndrome due to Ritonavir-Fluticasone Interaction

Ritonavir is commonly used in low doses to boost plasma levels of protease inhibitors in patients with human immunodeficiency virus (HIV) infections. It is also a potent inhibitor of cytochrome P450. We present a 50-year-old African American male with past medical history of HIV on highly active ant...

Descripción completa

Detalles Bibliográficos
Autores principales: Tiruneh, Fasil, Awan, Ahmad, Didana, Abiot, Doshi, Saumil
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2017
Materias:
Infectious Disease
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5602273/
https://www.ncbi.nlm.nih.gov/pubmed/28944123
http://dx.doi.org/10.7759/cureus.1484

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5602273/
https://www.ncbi.nlm.nih.gov/pubmed/28944123
http://dx.doi.org/10.7759/cureus.1484

Ejemplares similares